Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;6(1):87-104.
doi: 10.1007/s40487-018-0056-8. Epub 2018 Feb 6.

Uveal Melanoma: A Review of the Literature

Affiliations

Uveal Melanoma: A Review of the Literature

Manni Singh et al. Oncol Ther. 2018 Jun.

Erratum in

Abstract

Melanomas affecting different components of the uvea occur with differing frequencies and clinical presentations. Uveal melanoma is diagnosed via funduscopic exam and ancillary tests. These lesions may present with visual findings or incidental findings on physical exam. Metastasis occurs in approximately half of all patients with primary uveal melanoma. The liver is the most common site of metastasis. Enucleation was at one time considered the definitive local treatment for primary uveal melanoma, but has been largely replaced by other therapeutic procedures that aim to prevent metastasis while preserving vision. Unfortunately, metastasis of uveal melanoma almost always proves to be fatal. The current treatment of metastatic uveal melanoma is limited by the intrinsic resistance of uveal melanoma to conventional systemic therapies. Advancements in molecular biology have resulted in the identification of a number of promising prognostic and therapeutic targets. Early detection and therapy are important factors in disease survival. It is imperative that the treating physician be familiar with the clinical features of uveal melanoma and distinguish it from mimickers in order to ensure effective and timely treatment.

Keywords: Choroid; Ciliary body; Iris; Melanoma; Review.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Fundoscopic image of choroidal melanoma
Fig. 2
Fig. 2
Fundoscopic image of ciliary body melanoma
Fig. 3
Fig. 3
Gross image of ciliary body melanoma with sentinel vessels
Fig. 4
Fig. 4
Gross image of iris melanoma
Fig. 5
Fig. 5
Gross image of iris melanoma

References

    1. Spagnolo F, Caltabiano G, Queirolo P. Uveal melanoma. Cancer Treat Rev. 2012;38:549–553. - PubMed
    1. Yonekawa Y, Kim IK. Epidemiology and management of uveal melanoma. Hematol Oncol Clin N Am. 2012;26:1170–1184. - PubMed
    1. Landerville S, Agapova OA, Harbour JW. Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol. 2008;4:629–636. - PMC - PubMed
    1. Nathan P, Cohen V, Coupland S, et al. Uveal melanoma UK national guidelines. Eur J Cancer. 2015. 10.1016/j.ejca.2015.07.013. - PubMed
    1. Shields CL, Manalac J, Das C, Ferguson K, Shields JA. Choroidal melanoma: clinical features, classification, and top 10 pseudomelanomas. Curr Opin Ophthalmol. 2014;25:177–185. - PubMed

LinkOut - more resources